Patent for BioProspect
Monday, 20 October, 2008
Brisbane company BioProspect (ASX: BPO) has been granted a patent on its Termilone product for termite control.
Termoline is based on ermophilone oil, extracted from the native Australian tree False Sandalwood.
The oil acts as both a toxic agent on termites and a repellant, but has shown low toxicity in mammalian species.
The company is also developing a range of Bioeffectives for the animal health and nutrition markets.
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
2026 Snow Fellowship recipients to receive $24m in biomedical funding
Australian biomedical researchers Dr Deborah Burnett, A/Prof Sudarshini Ramanathan and Dr Ira...
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
